Aarti Pharmalabs Limited Cash Flow Quality Index
Aarti Pharmalabs Limited cash flow quality index. Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow Quality Index of 0.71x as of December 2023. Operating cash flow of Rs375.40 Million is below net income of Rs527.60 Million, suggesting accrual-heavy earnings not yet converted to cash. See AARTIPHARM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Aarti Pharmalabs Limited (2022–2025)
Cash flow quality index of Aarti Pharmalabs Limited from 2022 to 2025. Historical Cash Flow Quality Index for Aarti Pharmalabs Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Aarti Pharmalabs Limited to assess how comfortably operating cash covers total debt obligations.
Aarti Pharmalabs Limited Cash Flow Quality Index by Year (2022–2025)
Aarti Pharmalabs Limited cash flow quality index by year from 2022 to 2025. Year-by-year earnings quality comparison for Aarti Pharmalabs Limited. For the full cash flow conversion analysis, see AARTIPHARM cash generation efficiency.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | Rs3.32 Billion | Rs2.72 Billion | ▲ +22.0% |
| 2024 | 1.00x | Rs2.16 Billion | Rs2.17 Billion | ▼ -1.1% |
| 2023 | 1.01x | Rs2.63 Billion | Rs2.61 Billion | ▲ +458.6% |
| 2022 | -0.28x | Rs-437.04 Million | Rs1.55 Billion | — |